Literature DB >> 9391788

Natural history of advanced hepatocellular carcinoma in Crete. Association with hepatitis C virus.

E A Kouroumalis1, P G Skordilis, J Moschandrea, G Alexandrakis, N Charoulakis, M Tzardi, O N Manousos.   

Abstract

OBJECTIVE: To investigate the clinical characteristics of advanced hepatocellular carcinoma (HCC) in Crete and to analyse the natural course of the untreated disease. PARTICIPANTS: Seventy-three patients (62 men) were enrolled in a prospective 4-year study. Clinical and virological parameters were recorded. Diagnosis was based on either ultrasound guided liver biopsy or a pathognomonic increase in alpha-fetoprotein plus compatible imaging.
METHODS: Statistical analysis was performed using histograms, contingency tables and one-way analyses of variance to analyse the characteristics of the disease. For survival analysis Kaplan-Meier survival curves and Cox's proportional hazards models were constructed.
RESULTS: HCC in Crete is a mostly male disease (7:1 male:female ratio) and unlike in mainland Greece, it is mostly a hepatitis C virus (HCV)-related disease (54% HCV positive as opposed to only 13% in mainland Greece). Prognosis was associated with Okuda classification (Okuda stage III patients have a relative risk of dying that is seven to nine times higher than for Okuda stage I), the presence or absence of hepatitis Be antigen (HBeAg) and antibody to hepatitis B core antigen (anti-HBc). By contrast the presence of anti-HCV was not associated with a worse prognosis. A unit increase of albumin concentration was associated with an 11% decrease in the hazard rate.
CONCLUSION: In general, Crete, despite the extremely similar population to the rest of Greece, resembles more closely the situation in Spain or Italy rather than mainland Greece.

Entities:  

Mesh:

Year:  1997        PMID: 9391788     DOI: 10.1097/00042737-199710000-00011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Authors:  Dimitrios N Samonakis; Mairi Koulentaki; Constantina Coucoutsi; Aikaterini Augoustaki; Chryssavgi Baritaki; Emmanuel Digenakis; Nikolaos Papiamonis; Maria Fragaki; Erminia Matrella; Maria Tzardi; Elias A Kouroumalis
Journal:  World J Hepatol       Date:  2014-07-27

2.  Risk factors for hepatocellular carcinoma in Turkey.

Authors:  O Uzunalimoğlu; C Yurdaydin; H Cetinkaya; H Bozkaya; T Sahin; S Colakoğlu; E Tankurt; M Sarioğlu; S Ozenirler; H Akkiz; N Tözün; H Değertekin; A Okten
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

3.  Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational study.

Authors:  M Koulentaki; M Ergazaki; J Moschandrea; S Spanoudakis; N Tzagarakis; P E Drandakis; D A Spandidos; E A Kouroumalis
Journal:  BMC Public Health       Date:  2001-12-21       Impact factor: 3.295

4.  Reporting Liver Cancer Trends in the Island of Crete, Greece: Results from a Geo-Epidemiological Study.

Authors:  Stavros Kalpadakis; Dimitra Sifaki-Pistolla; Emmanouil K Symvoulakis; Panagiotis Kelefiotis-Stratidakis; Lambros Vamvakas; Dimitrios Mavroudis; Christos Lionis
Journal:  Int J Environ Res Public Health       Date:  2022-08-17       Impact factor: 4.614

Review 5.  Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Liver Int       Date:  2008-12-24       Impact factor: 5.828

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.